This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/uk/527157-uk-novavax-booster-covid19-vaccine/

The article has changed 3 times. There is an RSS feed of changes available.

Version 0 Version 1
UK preparing for autumn booster shots against Covid-19, says minister, as CureVac fails and Novavax shines in trials UK preparing for autumn booster shots against Covid-19, says minister, as CureVac fails and Novavax shines in trials
(2 months later)
The UK health minister has said the government will shortly be announcing its plans for nationwide booster shots against Covid-19 in the autumn, as a trial of different combinations nears its conclusion.The UK health minister has said the government will shortly be announcing its plans for nationwide booster shots against Covid-19 in the autumn, as a trial of different combinations nears its conclusion.
Speaking to BBC Breakfast on Monday, Health Secretary Matt Hancock said the authorities were currently trialing a number of vaccine combinations that could boost Britons’ immunity against the novel coronavirus and its many variants. Speaking to BBC Breakfast on Monday, Health Secretary Matt Hancock said the authorities were currently trialing a number of vaccine combinations that could boost Britons’ immunity against the novel coronavirus and its many variants. 
“In the next few weeks, when we get the clinical data through on what’s the most effective combinations to have … then we’ll set out all the details for the booster programme for the autumn,” Hancock stated.“In the next few weeks, when we get the clinical data through on what’s the most effective combinations to have … then we’ll set out all the details for the booster programme for the autumn,” Hancock stated.
The UK’s Cov-Boost trial, which tests a variety of vaccine combos, has become increasingly relevant, given the current prevalence of the Indian virus variant, known as Delta. The UK’s Cov-Boost trial, which tests a variety of vaccine combos, has become increasingly relevant, given the current prevalence of the Indian virus variant, known as Delta. 
Scientists, including Dr Susan Hopkins, strategic response director for Covid-19 at Public Health England, have warned of the prospect of further lockdowns later in the year. “I can’t predict the future – it really depends on whether the hospitals start to become overwhelmed at some point,” Hopkins told the BBC’s Andrew Marr. Scientists, including Dr Susan Hopkins, strategic response director for Covid-19 at Public Health England, have warned of the prospect of further lockdowns later in the year. “I can’t predict the future – it really depends on whether the hospitals start to become overwhelmed at some point,” Hopkins told the BBC’s Andrew Marr. 
On Sunday, the day before the UK’s lockdown was originally scheduled to end, the country registered 9,284 Covid-19 cases, many of which are the Delta variant. On Sunday, the day before the UK’s lockdown was originally scheduled to end, the country registered 9,284 Covid-19 cases, many of which are the Delta variant. 
The UK had hoped that CureVac, a German biotech firm, would provide a booster jab for the country this autumn. However, last week, the company’s trial revealed that its vaccine was only 47% effective. The UK had hoped that CureVac, a German biotech firm, would provide a booster jab for the country this autumn. However, last week, the company’s trial revealed that its vaccine was only 47% effective. 
Meanwhile, US firm Novavax published extremely positive trial data last week, with its vaccine proving more than 90% effective against a variety of virus variants. The jab will be produced in the UK, if granted approval. Meanwhile, US firm Novavax published extremely positive trial data last week, with its vaccine proving more than 90% effective against a variety of virus variants. The jab will be produced in the UK, if granted approval. 
If you like this story, share it with a friend!If you like this story, share it with a friend!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.